Travere TherapeuticsTVTX
13F holders, Q2 2025 (June 30)212holders −6
39new positions
45sold out
8famous investors
$14.80avg. 13F price*
At the end of Q2 2025, 212 institutions reported holding Travere Therapeutics Inc. (TVTX) in their 13F filings, down 6 from Q1 2025. 39 opened new positions and 45 sold out. The largest holders were Janus Henderson Group PLC ($141.2M), Armistice Capital, LLC ($131.4M) and BlackRock, Inc. ($120.9M). 8 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Paul Tudor Jones (0.0% of Tudor Investment Corporation's portfolio) and David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio).
- Company
- Travere Therapeutics Inc.
- CUSIP
- 89422G107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 39 | $90.8M |
| Exits | 45 | $137.5M |
All 13F filers, Q1 2025 → Q2 2025: 16,678,670 shares bought and 14,195,537 shares sold, net +2,483,133 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 212 holders
| Janus Henderson Group PLC | 0.07% | Add +26.7% | 9,541,270 | $141.2M |
| Armistice Capital, LLC | 4.98% | Add +0.1% | 8,876,000 | $131.4M |
| BlackRock, Inc. | 0.00% | Reduce -0.3% | 8,168,951 | $120.9M |
| Vanguard Group Inc. | 0.00% | Add +19.6% | 5,994,283 | $88.7M |
| Macquarie Group Ltd. | 0.09% | Add +6.3% | 5,097,482 | $75.4M |
| State Street Corp. | 0.00% | Reduce -4.5% | 3,483,176 | $51.6M |
| Adage Capital Partners Gp, L.L.C. | 0.07% | Add +27.4% | 2,784,000 | $41.2M |
| Renaissance Technologies | 0.05% | Reduce -7.7% | 2,495,114 | $36.9M |
| Emerald Advisers, LLC | 1.13% | Add +0.7% | 2,091,360 | $31.0M |
| Geode Capital Management, LLC | 0.00% | Add +1.4% | 2,003,701 | $29.7M |
| Rock Springs Capital Management LP | 1.77% | Reduce -34.7% | 1,908,208 | $28.2M |
| Bank of America Corp. | 0.00% | Add +71.4% | 1,621,393 | $24.0M |
| Morgan Stanley | 0.00% | Reduce -4.5% | 1,568,544 | $23.2M |
| Goldman Sachs Group Inc. | 0.00% | Add +79.4% | 1,556,852 | $23.0M |
| Kynam Capital Management, LP | 2.46% | Reduce -14.5% | 1,540,691 | $22.8M |
| Eversept Partners, LP | 1.96% | Add +61.1% | 1,315,033 | $19.5M |
| Nuveen, LLC | 0.00% | Reduce -0.8% | 1,194,335 | $17.7M |
| Ra Capital Management, L.P. | 0.29% | No change | 1,150,000 | $17.0M |
| Emerald Mutual Fund Advisers Trust | 1.03% | Add +1.7% | 1,141,428 | $16.9M |
| D. E. Shaw & Co. | 0.02% | Reduce -34.0% | 1,130,750 | $16.7M |
| Assenagon Asset Management S.A. | 0.03% | Add +166.8% | 1,103,075 | $16.3M |
| FMR LLC | 0.00% | Reduce -1.3% | 1,067,773 | $15.8M |
| Two Sigma Advisers, LP | 0.03% | Add +1.1% | 1,057,700 | $15.7M |
| Frazier Life Sciences Management, L.P. | 0.59% | New | 1,002,092 | $14.8M |
| Affinity Asset Advisors, LLC | 2.21% | Reduce -9.3% | 970,000 | $14.4M |
| Two Sigma Investments, LP | 0.03% | Add +19.5% | 918,713 | $13.6M |
| Aberdeen Group plc | 0.02% | Add +86.7% | 896,594 | $13.3M |
| Ensign Peak Advisors, Inc | 0.02% | Add +72.2% | 858,834 | $12.7M |
| Perceptive Advisors LLC | 0.46% | New | 834,252 | $12.3M |
| Parkman Healthcare Partners LLC | 1.42% | Reduce -13.3% | 827,060 | $12.2M |
| Northern Trust Corp. | 0.00% | Reduce -1.0% | 800,628 | $11.8M |
| JPMorgan Chase & Co. | 0.00% | Add +25.4% | 771,830 | $11.4M |
| Jennison Associates LLC | 0.01% | Reduce -9.5% | 771,522 | $11.4M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +12.7% | 771,296 | $11.4M |
| Voloridge Investment Management, LLC | 0.04% | Reduce -37.0% | 744,654 | $11.0M |
| Marshall Wace, LLP | 0.01% | New | 742,725 | $11.0M |
| Jacobs Levy Equity Management, Inc. | 0.04% | Reduce -14.8% | 735,251 | $10.9M |
| Citadel Advisors | 0.01% | Add +35.6% | 711,257 | $10.5M |
| Tang Capital Management LLC | 0.52% | New | 700,000 | $10.4M |
| Cubist Systematic Strategies, LLC | 0.11% | New | 699,182 | $10.3M |
| Connor, Clark & Lunn Investment Management Ltd. | 0.04% | Add +38.4% | 685,511 | $10.1M |
| UBS Group AG | 0.00% | Reduce -7.8% | 650,281 | $9.6M |
| Qube Research & Technologies Ltd | 0.01% | Add +106.2% | 604,128 | $8.9M |
| Pictet Asset Management Holding SA | 0.01% | Reduce -10.5% | 595,681 | $8.8M |
| Barclays PLC | 0.00% | Reduce -35.7% | 528,526 | $7.8M |
| Federated Hermes, Inc. | 0.01% | Reduce -21.6% | 527,538 | $7.8M |
| Deutsche Bank AG | 0.00% | Reduce -1.8% | 516,548 | $7.6M |
| Candriam S.C.A. | 0.04% | Reduce -4.0% | 512,681 | $7.6M |
| Invesco Ltd. | 0.00% | Reduce -9.7% | 510,919 | $7.6M |
| Legal & General Group Plc | 0.00% | Add +23.6% | 510,428 | $7.6M |
| Woodline Partners LP | 0.04% | Reduce -59.3% | 500,995 | $7.4M |
| Squarepoint Ops LLC | 0.02% | Add +120.9% | 479,394 | $7.1M |
| Impax Asset Management Group plc | 0.04% | Add +58.3% | 475,000 | $7.0M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Add +569.0% | 445,557 | $6.6M |
| Loomis Sayles & Co. L P | 0.01% | Reduce -41.3% | 439,341 | $6.5M |
| Panagora Asset Management Inc. | 0.03% | Add +28.6% | 432,021 | $6.4M |
| Schroder Investment Management Group | 0.01% | Reduce -29.1% | 420,512 | $6.2M |
| Royce & Associates LP | 0.06% | New | 380,997 | $5.6M |
| Vestal Point Capital, LP | 0.28% | New | 355,000 | $5.3M |
| PDT Partners, LLC | 0.29% | Add +12.9% | 349,577 | $5.2M |
| Alliancebernstein L.P. | 0.00% | Reduce -17.9% | 343,861 | $5.1M |
| Sphera Funds Management LTD. | 1.30% | Add +67.7% | 335,333 | $5.0M |
| Lord, Abbett & Co. LLC | 0.02% | Reduce -45.2% | 309,230 | $4.6M |
| GW&K Investment Management, LLC | 0.04% | Reduce -12.0% | 282,500 | $4.2M |
| Superstring Capital Management LP | 5.10% | Add +16.4% | 276,474 | $4.1M |
| Knott David M Jr | 1.74% | Add +14.0% | 260,000 | $3.8M |
| Prudential Financial Inc. | 0.00% | Add +0.3% | 244,256 | $3.6M |
| First Trust Advisors LP | 0.00% | New | 239,045 | $3.5M |
| Russell Investments Group, Ltd. | 0.00% | Add +5.7% | 237,720 | $3.5M |
| Bank of New York Mellon Corp | 0.00% | Reduce -1.2% | 231,145 | $3.4M |
| AQR Capital Management | 0.00% | Reduce -42.9% | 228,093 | $3.4M |
| Millennium Management | 0.00% | Add +249.3% | 208,991 | $3.1M |
| Tudor Investment Corporation | 0.02% | Add +23.3% | 201,508 | $3.0M |
| Walleye Capital LLC | 0.03% | Reduce -28.7% | 191,867 | $2.8M |
| F/m Investments LLC | 0.10% | Add +27.3% | 187,734 | $2.8M |
| BNP Paribas Financial Markets | 0.00% | Add +19.0% | 175,033 | $2.6M |
| Hussman Strategic Advisors, Inc. | 0.57% | New | 168,000 | $2.5M |
| Point72 Asset Management | 0.01% | New | 167,896 | $2.5M |
| Voya Investment Management LLC | 0.00% | Add +36.5% | 167,721 | $2.5M |
| Hillsdale Investment Management Inc. | 0.09% | New | 163,400 | $2.4M |
| Swiss National Bank | 0.00% | Add +1.9% | 161,100 | $2.4M |
| Exome Asset Management LLC | 1.87% | Add +29.9% | 153,278 | $2.3M |
| Man Group plc | 0.00% | Add +185.1% | 139,044 | $2.1M |
| Rhumbline Advisers | 0.00% | Add +6.0% | 131,959 | $2.0M |
| ExodusPoint Capital Management, LP | 0.02% | New | 128,157 | $1.9M |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 0.00% | Reduce -62.4% | 127,582 | $1.9M |
| Algert Global LLC | 0.04% | Add +686.7% | 127,188 | $1.9M |
| Rafferty Asset Management, LLC | 0.01% | Reduce -14.6% | 123,854 | $1.8M |
| Sio Capital Management, LLC | 0.73% | Add +1.0% | 122,210 | $1.8M |
| Engineers Gate Manager LP | 0.02% | Add +23.4% | 110,807 | $1.6M |
| Palo Alto Investors LP | 0.35% | No change | 110,719 | $1.6M |
| Susquehanna International Group, LLP | 0.00% | Reduce -10.9% | 109,787 | $1.6M |
| Birchview Capital, LP | 1.51% | Reduce -25.4% | 103,000 | $1.5M |
| Capital Fund Management S.A. | 0.02% | New | 101,406 | $1.5M |
| Rice Hall James & Associates, LLC | 0.07% | Add +5.6% | 93,612 | $1.4M |
| Gsa Capital Partners LLP | 0.09% | New | 88,195 | $1.3M |
| Sei Investments Co. | 0.00% | Add +147.3% | 80,142 | $1.2M |
| Franklin Resources Inc. | 0.00% | Add +44.8% | 76,511 | $1.1M |
| Ameriprise Financial Inc. | 0.00% | Reduce -24.3% | 73,661 | $1.1M |
| Trexquant Investment LP | 0.01% | Reduce -53.7% | 72,344 | $1.1M |
"% of holder's portfolio" is TVTX's weight in each manager's 13F, not the share of Travere Therapeutics Inc. the manager owns.